Search

for
Search:

GlossaryDipeptidyl Peptidase-4 (DPP-4)

enzyme that breaks down incretin hormones, regulating insulin levels

Dipeptidyl Peptidase-4 (DPP-4) is an enzyme that plays a role in glucose metabolism by breaking down incretin hormones, which help regulate insulin levels in the body. It is also known as CD26 and is involved in immune system functions. Inhibitors of DPP-4 are used in the treatment of type 2 diabetes to improve blood sugar control.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 198 results

research DPP-4 Inhibition with Linagliptin Ameliorates the Progression of Premature Aging in Klotho−/− Mice

20 citations, December 2017 in “Cardiovascular diabetology”

Linagliptin slows down premature aging in certain mice.

research A Peptide Derivative with Known Anti-Wrinkle Properties Identified as Potent Dipeptidylpeptidase-4 Inhibitor

April 2016 in “Journal of Investigative Dermatology”

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

research Basic Mechanisms of SARS-CoV-2 Infection: Implications for Endocrine Systems

14 citations, July 2021 in “Reviews in endocrine and metabolic disorders”

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

research Linagliptin-Associated Alopecia and Bullous Pemphigoid

7 citations, September 2019 in “European Journal of Case Reports in Internal Medicine”

Linagliptin may cause hair loss and skin blisters.

research Alopecia Universalis After Sitagliptin Intake

2 citations, November 2020 in “Der Hautarzt”

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

View more "dpp-4" in research →

Community Join

0 / 0 results

— no results